For full review of the trial, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
Summary and discussion of ANDROMEDA, ATHENA and PALLAS
For full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe
In this episode, Dr. Harlan Krumholz introduces the September 16, 2025 issue of JACC, which features studies that challenge conventional clinical thinking, including a detailed ECMO physiology study showing that higher ECMO flow does not uniformly raise pulmonary capillary wedge ...Show more
Eagle’s Eye View: Inflammation and Cholesterol are Predictors of CV Events
In this week's View, Dr. Eagle looks at a collaborative analysis of three randomized trials that investigated inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy. He then covers the 2023 ACC Expert Consensus Decision Pathway ...Show more
<ul> <li style="font-weight: 400;" aria-level="1"><span style= "font-weight: 400;">The presence of a STEMI has traditionally been used to determine if a patient with acute chest pa ...Show more
Four pillars of cardiology today, stable coronary artery disease, severe aortic stenosis, the evaluation of chest pain, and best therapies for atrial fibrillation are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professio ...Show more